We speculate that low urinary excretion rates of dopamine and DOPAC in PD reflect decreased local activity of L-aromatic-amino-acid decarboxylase (LAAAD), the enzyme that catalyzes the conversion of DOPA to dopamine, or decreased renal uptake of circulating DOPA via NAATs. This evidence concerns the gene DDC and Parkinson disease.